Purchase Order 75F40122P00488
Award Date 9/13/22
Potential Completion Date 3/7/28
Potential Value $87K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10013, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company, provides a software license and device warranty for two GridION instruments to support the Food and Drug Administration's (FDA) next-generation sequencing efforts. The $25,000.00 firm-fixed-price purchase order has a period of performance through September 27, 2025. Oxford Nanopore Technologies is a provider of innovative nanopore-based sequencing platforms, which have been...
- Oxford Nanopore Technologies Inc. was awarded a $100,060 firm fixed-price purchase order by the U.S. Department of Health and Human Services Food and Drug Administration (FDA) for a total small business set-aside requirement of two portable long-read whole genome sequencers to support the FDA's epidemiologic investigations and surveillance for foodborne pathogens like Escherichia coli and Clostridium botulinum. The sequencers and associated consumables, support, and installation services are...
- This $6,678 firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company that develops and provides nanopore-based electronic DNA/RNA sequencing systems. The award does not have a set-aside designation. Through this contract, Oxford Nanopore is providing its next-generation sequencing equipment, consumables, and...
- The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $225,000.00 firm fixed-price purchase order contract to Oxford Nanopore Technologies Inc., a division of Oxford Nanopore Technologies PLC, for a PromethION 24 compact benchtop sequencing system. This system is designed to run and analyze up to 24 PromethION Flow Cells, delivering yields of up to 4,800 Gigabases. The contract has a one-year base period with three one-year option years. This award was...
- This is a $125,000.00 firm fixed price purchase order awarded by the Food and Drug Administration (FDA) to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is for a service agreement to provide Oxford Nanopore's GridION instruments located at the FDA's Center for Food Safety and Applied Nutrition, Office of Regulatory Science. This award is not set aside for any small business program. Oxford Nanopore has secured numerous federal contracts to...
- This federal contract award is for the purchase of specific supplies and reagents for an Oxford Nanopore GridION instrument, awarded to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract, valued at $29,162.00, is a firm fixed-price purchase order placed by the Food and Drug Administration (FDA), a civilian government agency. The award is not associated with a set-aside program and has an ultimate completion date of March 29, 2024. Oxford Nanopore...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, for a service contract to provide Oxford Nanopore GridION instruments. The contract has a total ceiling value of $50,000.00 and a completion date of February 5, 2023. The contract is not associated with any set-aside designation. Oxford Nanopore Technologies Inc. is a provider of next-generation genomic...
- Oxford Nanopore Technologies Inc. was awarded a $25,000 firm fixed price purchase order by the Department of Health and Human Services Food and Drug Administration to deliver GridION software licenses. The solicitation sought GridION software or equal, including device warranty. As a foreign owned for-profit organization, Oxford Nanopore Technologies Inc. develops nanopore sequencing systems and supplies consumables to support genomic research. They have provided equipment, reagents, kits and...
- Oxford Nanopore Technologies Inc. was awarded a $47,960 firm fixed-price purchase order by a civilian federal agency (Midwest Area) on December 6, 2019, for genomic sequencing consumables and reagents. The contract, which was set aside for total small business, called for the delivery of MinION flow cells (FLO-MIN 106D R9 and FLO-MIN 110 R10 models) and ligation sequencing kits (SQK-LSK109), with an ultimate completion date of December 20, 2019. The place of performance was Cambridge, MA, and...
- Oxford Nanopore Technologies Inc. received a $95,605 firm fixed-price purchase order (Contract #GRD-CAPEX) from a civilian Southeast Area federal agency for genomic sequencing equipment and services, with performance in Cambridge, Massachusetts. The contract was awarded on September 5, 2019, with an ultimate completion date of October 4, 2019. This award was not associated with a small business set-aside designation. Oxford Nanopore Technologies Inc., a foreign-owned biotechnology firm...